Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified four key cuproptosis-related lncRNAs (CRLs) that predict outcomes in bladder urothelial carcinoma (BLCA). This prognostic signature helps stratify patients and may guide treatment decisions for this lethal cancer.
Area Of Science
- Oncology
- Molecular Biology
- Genomics
Background
- Bladder urothelial carcinoma (BLCA) is a significant cause of cancer-related mortality.
- The role and prognostic implications of cuproptosis-related lncRNAs (CRLs) in BLCA remain largely unexplored.
- Cuproptosis, a novel form of cell death induced by copper, presents a new avenue for cancer research.
Purpose Of The Study
- To investigate the prognostic value of CRLs in BLCA.
- To develop a prognostic signature based on CRLs for BLCA patients.
- To explore the potential of this signature in predicting treatment responses.
Main Methods
- Utilized RNA-seq data and clinical information from The Cancer Genome Atlas (TCGA) for 414 BLCA samples.
- Employed univariate and multivariate Cox regression analyses to identify prognostic CRLs.
- Validated the prognostic signature using Kaplan-Meier analysis and gene set enrichment analysis (GSEA).
Main Results
- A prognostic signature comprising four independent CRLs (RC3H1-IT1, SPAG5-AS1, FAM13A-AS1, and GNG12-AS1) was developed.
- The signature effectively predicted overall survival in BLCA patients, with high-risk groups exhibiting poorer outcomes.
- High-risk patients showed enrichment in tumor- and immune-related pathways and demonstrated potentially enhanced responses to immunotherapy and specific chemotherapies.
Conclusions
- The identified 4-CRLs prognostic signature serves as an independent predictor of prognosis in BLCA.
- This signature offers insights into the mechanisms of CRLs in BLCA progression.
- The findings may guide clinical treatment strategies and personalized therapy for BLCA patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
